Literature DB >> 9861922

Chronic solvent neurotoxicity in New Zealand: notified cases between 1993 and 1997.

E W Dryson1, J A Ogden.   

Abstract

AIM: To report on cases of chronic solvent neurotoxicity notified to the Department of Labour between 1993 and 1997.
METHODS: Previously published diagnostic criteria were used to classify notified cases as "verified", "not verified" or "not proven". Verified cases were further classified as Type 1 or 2(2) and analysed according to occupation, solvent type and length of exposure.
RESULTS: Of 193 notified cases, 76 were classified as "verified". The majority were male (74/76) and European (69/76). Mean length of exposure to solvents for Type I cases was 10.6 years (SD 4.7) and for Type II cases 19.8 years (SD 8.4). Forty-three cases were classified as "mild" and 33 as "moderate". The most frequent occupation was spraypainting (39%), followed by printing (16%) and boatbuilding (9%). There was no correlation between severity of symptoms and type of solvent. There was a non-significant trend of increasing severity of symptoms with length of exposure.
CONCLUSION: Exposure to solvents is an important health hazard in New Zealand workplaces.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861922

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  3 in total

1.  Routine diagnostic procedures for chronic encephalopathy induced by solvents: survey of experts.

Authors:  J A van der Hoek; M M Verberk; G van der Laan; G Hageman
Journal:  Occup Environ Med       Date:  2001-06       Impact factor: 4.402

2.  Work ability score of solvent-exposed workers.

Authors:  Heidi Furu; Markku Sainio; Hanna-Kaisa Hyvärinen; Ari Kaukiainen
Journal:  Int Arch Occup Environ Health       Date:  2018-03-28       Impact factor: 3.015

3.  Occupational chronic solvent encephalopathy in Finland 1995-2007: incidence and exposure.

Authors:  Petra Keski-Säntti; Ari Kaukiainen; Hanna-Kaisa Hyvärinen; Markku Sainio
Journal:  Int Arch Occup Environ Health       Date:  2009-11-26       Impact factor: 3.015

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.